humanitarian
Archived signal
Human medicines European public assessment report (EPAR): Arsenic trioxide Accord, arsenic trioxide, Date of authorisation: 14/11/2019, Revision: 9, Status: Authorised
Human medicines European public assessment report (EPAR): Pemetrexed Baxter, pemetrexed, Date of authorisation: 09/12/2022, Status: Withdrawn
Reported by EMA What Is New
Read the complete report at EMA What Is New ↗
Verification notice
IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.
12 reports · 2 sources
EMA What Is NewHuman medicines European public assessment report (EPAR): Arsenic trioxide Accord, arsenic trioxide, Date of authorisation: 14/11/2019, Revision: 9, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Arsenic trioxide Accord, arsenic trioxide, Date of authorisation: 14/11/2019, Revision: 9, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Rasilez, aliskiren, Date of authorisation: 22/08/2007, Revision: 29, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Rasilez, aliskiren, Date of authorisation: 22/08/2007, Revision: 29, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Ordspono, odronextamab, Date of authorisation: 22/08/2024, Revision: 2, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Ordspono, odronextamab, Date of authorisation: 22/08/2024, Revision: 2, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Sialanar, glycopyrronium bromide, Date of authorisation: 15/09/2016, Revision: 13, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Sialanar, glycopyrronium bromide, Date of authorisation: 15/09/2016, Revision: 13, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Andembry, garadacimab, Date of authorisation: 10/02/2025, Revision: 2, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Andembry, garadacimab, Date of authorisation: 10/02/2025, Revision: 2, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Sprycel, dasatinib (anhydrous), Date of authorisation: 20/11/2006, Revision: 48, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Sprycel, dasatinib (anhydrous), Date of authorisation: 20/11/2006, Revision: 48, Status: Authorised2 recorded states
Signal first indexedP2 · 99% quality · 2 sources
Headline updatedP2 · 99% quality · 2 sources